The problem is also that this class of drugs (modified peptides) is produced in a very different way from most drugs (small molecules). When small molecule GLP-1 receptor agonists hit the market the shortage will be over very quickly. There is a lot of capacity to produce small molecules in place already. Many companies are currently racing to bring small molecules to market.

Was on the BBC that now people are buying it from the black market to lose weight for beach bodies